Company Directory / Medical Device

Kardium logo

PrivateFor profitMedical DeviceBurnaby, BC, Canada

Kardium

Kardium develops medical devices for the diagnosis and treatment of atrial fibrillation.

Founded
2007
19 years ago
Staff
101-250
387 on LinkedIn
Followers
15k
on LinkedIn
Funding
$220M
as listed, USD

Kardium is developing a revolutionary medical device for the diagnosis and treatment of atrial fibrillation. .

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

101-250 people: larger than 85% of companies with a size listed. 387 people list it on LinkedIn.

Age

200719002026

19 years old.

Reach

Website ranked #3,595,032 in the world for traffic, about 4k visits a month. 15,171 followers on LinkedIn.

What it does

HardwareHealth DiagnosticsMedical Device

Funding, as listed

$220M raised in total

  • Rounds5
  • LatestPrivate equity, Jun 2024
  • Latest amountUSD 103,961,062
  • Investors4, 2 leading

What the source datasets report. We have not watched these rounds ourselves.

FoundersDan Gelbart, Sam Lichtenstein

Every detail we hold

Everything the source datasets list about Kardium, field by field. Contact details are held but never shown.

The company

Name
Kardium
Type
For profit
Status
Private
Founded
2007
Founders
Dan Gelbart, Sam Lichtenstein
Industry
Medical Device
Categories
Hardware, Health Diagnostics, Medical Device

Where

City
Burnaby
Region
BC
Country
Canada

Size and reach

Staff band
101-250
People on LinkedIn
387
LinkedIn followers
15,171
Web traffic rank
#3,595,032
Monthly web visits
3,579

Funding, as listed

Total
$219,971,108 USD
Rounds
5
Latest round
Private equity
Latest round date
Jun 2024
Latest amount
103,961,062 USD
Investors
4
Lead investors
2
Listing status
private

About this record

Sources
Crunchbase, LinkedIn
Last imported
Sept 2026

Growth, as the source summarises it

Kardium announced the completion of paroxysmal enrollment in the PULSAR IDE study. The company also secured $143 million CAD to help bring its irregular heartbeat treatment to market. Additionally, Kardium raised $104 million for its pulsed field ablation system and announced enhanced clinical capabilities of the Globe® System with right atrial ablation and hybrid energy ablation. Kardium reported positive 1-year outcomes for the PULSE-EU trial with the Globe® System.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

Medical Device in Canada.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 136,547 companies in Canada and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.